loader

Disclaimer

The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above
Close

Search

See all results for ""
RA

Reshma Abraham

, Mumbai

Counsel | Corporate & Commercial, Mergers and Acquisitions, Private Equity

education

  • B.A. LL.B. (Hons.), The National University of Advanced Legal Studies (2014)
  • LL.M., National University of Singapore (2019)

Reshma Abraham is a Counsel in the Mumbai office, specialising in M&A, private equity, joint ventures and strategic corporate advisory. She advises financial sponsors, strategic acquirers and promoter groups on acquisitions, investments, exits and regulatory issues across a range of sectors, including pharmaceuticals, healthcare and life sciences, renewable energy, agri-tech and industrials.

Professional Affiliations

  • Bar Council of Kerala

Representative Matters

Reshma Abraham has represented and advised the following clients

Apax Partners

Advised on its exit from Healthium Medtech Limited, a leading Indian medical devices company, through the sale of its stake to KKR for an enterprise value of approximately INR 7,000 crore. The transaction was recognised as one of the IBLJ Deals of the Year 2024

TPG Growth

Advised on its acquisition of a majority stake in Siemens Gamesa’s onshore WTG business in India and Sri Lanka, as part of a strategic partnership with Siemens Gamesa and MAVCO to create an independent renewable energy platform

Advent International Corporation

Advised on the acquisition of: (a) RA Chem Pharma Limited, a pharmaceutical CDMO and manufacturer of APIs and formulations; and (b) Avra Laboratories Private Limited, a specialty pharmaceutical company focused on APIs, intermediates, and custom synthesis services

Taparia Family

Advised on its exit from Famy Life Sciences Private Limited, an ophthalmology-focused pharmaceutical company, through the sale of its stake to Viatris Inc. (formerly Mylan Pharmaceuticals, Inc.) for approximately US$ 300 million

Novo Holdings A/S

Advised on its acquisition of a minority stake in AgNext Technologies Private Limited, an agri-tech company providing AI-powered quality assessment and traceability solutions for agricultural and food supply chains

Klass Pack Limited (a Borosil group company)

Advised on its acquisition of Goel Scientific Glass Works Limited, a manufacturer of industrial glass process systems and laboratory glassware